Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

10.7%

3 terminated out of 28 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

18%

5 trials in Phase 3/4

Results Transparency

42%

5 of 12 completed with results

Key Signals

5 with results80% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (11)
P 1 (1)
P 2 (3)
P 3 (3)
P 4 (2)

Trial Status

Completed12
Unknown6
Recruiting4
Terminated3
Withdrawn2
Active Not Recruiting1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (28)

Showing 20 of 20 trials
NCT04553757Active Not Recruiting

Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma

NCT04999046Not ApplicableCompleted

NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy

NCT06388707Phase 1Recruiting

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

NCT03822741Recruiting

Etiology and Treatment of Neonatal Seizure

NCT03233399Not ApplicableRecruiting

Modulating Movement Intention Via Cortical Stimulation

NCT03484039Not ApplicableCompleted

Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy

NCT06265103Recruiting

Epilepsy Learning Healthcare System (ELHS)

NCT06542952Completed

Statistical Analysis of Prevalence, Incidence, Comorbidities and Medical Expense in Epileptic Children in Taiwan Based on National Health Research Insurance Database.

NCT02682927Phase 3Completed

A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome

NCT03934268Unknown

A Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy

NCT04650204Phase 4Terminated

Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy

NCT04102254Not ApplicableWithdrawn

Thalamic Stimulation for Epilepsy Study

NCT04439656Completed

Detecting Absence Seizures Using Eye Tracking

NCT03790436Not ApplicableTerminated

Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet

NCT03441867Not ApplicableUnknownPrimary

Neuroimaging Biomarker for Seizures

NCT03480555Not ApplicableCompleted

Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients

NCT04377425Withdrawn

COVID-19 Prevalence and Cognitive Deficits in Neurological Patients

NCT04291716Not ApplicableUnknown

Study to Validate Novel Seizure-Detection Algorithm

NCT03513757Phase 4Completed

Dexmedetomidine and Propofol for Pediatric MRI Sedation

NCT00179517Phase 2CompletedPrimary

Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo

Scroll to load more

Research Network

Activity Timeline